Juno Therapeutics

Bristol Myers Squibb takes its CAR-T patent case to US' top court in bid to revive $1.2B verdict against Gilead
Fierce Pharma
Thu, 06/16/22 - 10:48 pm
Bristol Myers Squibb
Gilead Sciences
patents
CAR-T
Juno Therapeutics
JW Therapeutics hauls in $300M IPO just as liso-cel-inspired CAR-T nears the finish line in China
Endpoints
Wed, 11/4/20 - 10:30 am
JW Therapeutics
IPOs
CAR-T
liso-cel
China
Hong Kong
Juno Therapeutics
WuXi AppTec
Juno joint venture seeks IPO haul to bring CAR-Ts to China
Fierce Biotech
Mon, 08/17/20 - 10:33 am
JW Therapeutics
Juno Therapeutics
WuXi AppTech
IPOs
Hong Kong
CAR-T
Sana Biotechnology raises more than $700M for cell, gene therapy efforts
MedCity News
Tue, 06/23/20 - 10:42 am
Sana Biotechnology
Juno Therapeutics
CAR-T
Motion denied: Gilead still on the hook for $1.5B in damages over CAR-T patent dispute with Bristol Myers Squibb
Endpoints
Wed, 04/1/20 - 09:33 am
Gilead Sciences
CAR-T
Bristol-Meyers Squibb
Juno Therapeutics
patents
Bristol-Myers wins $752 million in U.S. patent case against Gilead
Reuters
Fri, 12/13/19 - 09:09 pm
Bristol-Myers Squibb
Gilead Sciences
Kite Pharma
patents
Juno Therapeutics
Celgene Gave This Tech Back to Editas Medicine, but It Could Prove Valuable
Motley Fool
Thu, 12/5/19 - 11:32 pm
Celgene
Editas Medicine
Juno Therapeutics
CRISPR
gene editing
Editas and Celgene sub Juno are tackling hottest immunotherapy cells
Endpoints
Tue, 11/12/19 - 08:07 pm
Editas Medicine
Celgene
Juno Therapeutics
CRISPR
gene editing
immunotherapy
Grail’s Cook Steps Down, Former Juno Executive Bishop Named CEO
BioCentury
Thu, 06/6/19 - 10:37 pm
Grail
diagnostics
Juno Therapeutics
Celgene
Seattle life sciences industry has strength in numbers despite uncertainty
Bizjournals
Fri, 05/3/19 - 10:20 am
Seattle
Juno Therapeutics
Celgene
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
Xconomy
Fri, 01/11/19 - 09:58 am
Celgene
M&A
Juno Therapeutics
Kite Therapeutics
Bluebird Bio
Agios Pharmaceuticals
Jounce Therapeutics
BieGene
Acceleron
Ex-Juno execs launch cell therapy start-up Sana
BioCentury
Sat, 01/5/19 - 12:07 am
Sana Biotechnology
R&D
cell therapy
gene therapy
Juno Therapeutics
Juno investors eke out $24M settlement in lawsuit over CAR-T trial deaths
Fierce Pharma
Wed, 09/5/18 - 09:58 pm
Juno Therapeutics
JCAR015
CAR-T
3 Best Biotech Acquisitions of 2018 (So Far)
Motley Fool
Thu, 07/5/18 - 09:57 am
M&A
biotech
Celgene
Juno Therapeutics
Novartis
AveXis
Roche
Foundation Medicine
4 Huge Pharma Deals in 4 Months Is Just the Beginning
Motley Fool
Sat, 04/28/18 - 12:18 pm
M&A
Takeda
Shire
Novartis
AveXis
Sanofi
Bioverativ
Celgene
Juno Therapeutics
Cell therapy flotations could follow Kite and Juno buyouts
EP Vantage
Wed, 03/7/18 - 06:24 pm
cell therapy
Kite Pharma
Juno Therapeutics
M&A
Unum Therapeutics
Autolus
Treatment Debates Won’t Slow Down Biotechs
Barron's
Fri, 02/23/18 - 09:50 am
biotech
Gilead Sciences
CAR-T
Juno Therapeutics
Bellicum
As CAR-Ts go from candidates to brands, what's the marketing strategy?
Medical Marketing and Media
Tue, 02/13/18 - 09:01 am
CAR-T
drug marketing
JCAR017
Juno Therapeutics
Celgene
bb2121
Bluebird Bio
apalutamide
Janssen
With Celgene buyout, Juno CEO Hans Bishop set for monster payout of $287M
Fierce Pharma
Mon, 02/5/18 - 12:30 pm
Celgene
Juno Therapeutics
Pharma CEOs
Hans Bishop
executive pay
Celgene Looking Good With Plans for More Growth
Motley Fool
Tue, 01/30/18 - 06:13 pm
Celgene
Juno Therapeutics

Pages